Evidence map›Paper›PMID 40100619›Full record

ArticleTissue engineering and regenerative medicine2025

Fabrication of 3D Biofunctional Magnetic Scaffolds by Combining Fused Deposition Modelling and Inkjet Printing of Superparamagnetic Iron Oxide Nanoparticles.

Manuel Estévez, Elisa Batoni, Mónica Cicuéndez, Amedeo Franco Bonatti, Tamara Fernández-Marcelo, Carmelo De Maria, Blanca González, Isabel Izquierdo-Barba, Giovanni Vozzi

Abstract read
In one paragraph

Article in Tissue engineering and regenerative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. 2D MoSNano convergence · 2026
    Article
  2. Biomimetic Scaffold of Chitosan fromAdvanced pharmaceutical bulletin · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Manuel Estévez *Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Instituto de Investigación Sanitaria, Universidad Complutense de Madrid, Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0001-7082-824X
Elisa Batoni *Department of Information Engineering, University of Pisa, Via Girolamo Caruso 16, 56122, Pisa, Italy.ORCID http://orcid.org/0000-0003-0247-6988
Mónica Cicuéndez *Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Universidad Complutense de Madrid, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-0427-4776
Amedeo Franco Bonatti *Research Center "E. Piaggio", University of Pisa, Via Largo Lucio Lazzarino 1, 56122, Pisa, Italy.ORCID http://orcid.org/0000-0001-7177-5135
Tamara Fernández-Marcelo *Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad Complutense de Madrid, Plaza Ramón y Cajal, s/n, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0001-6550-3838
Carmelo De Maria *Department of Information Engineering, University of Pisa, Via Girolamo Caruso 16, 56122, Pisa, Italy. carmelo.demaria@unipi.it.ORCID http://orcid.org/0000-0002-1368-3571
Blanca González *Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Instituto de Investigación Sanitaria, Universidad Complutense de Madrid, Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-0493-6071
Isabel Izquierdo-Barba *Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Instituto de Investigación Sanitaria, Universidad Complutense de Madrid, Hospital 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040, Madrid, Spain. ibarba@ucm.es.ORCID http://orcid.org/0000-0002-4139-4646
Giovanni Vozzi *Department of Information Engineering, University of Pisa, Via Girolamo Caruso 16, 56122, Pisa, Italy.ORCID http://orcid.org/0000-0002-9414-9994

Funding

Horizon 2020 Framework Programme 814410
6 · The paper itself

Abstract

backgroundRecently, magnetic composite biomaterials have raised attention in bone tissue engineering as the application of dynamic magnetic fields proved to modulate the proliferation and differentiation of several cell types.

methodsThis study presents a novel method to fabricate biofunctional magnetic scaffolds by the deposition of superparamagnetic iron oxide nanoparticles (SPIONs) through thermal Drop-On-Demand inkjet printing on three-dimensional (3D) printed scaffolds. Firstly, 3D scaffolds based on thermoplastic polymeric composed by poly-L-lactic acid/poly-caprolactone/poly(3-hydroxybutyrate-co-3-hydroxyvalerate) were fabricated by Fused Deposition Modelling. Then, in a second step, SPIONs were incorporated onto the surface of the scaffolds by inkjet printing following a designed 2D pattern.

resultsA complete characterization of the resulting magnetic scaffolds was carried out attending to the surface SPIONs deposits, demonstrating the accuracy and versatility of the production technique, as well as the stability under physiological conditions and the magnetic properties. Biological evaluation with human bone marrow mesenchymal stems cells demonstrated biocompatibility of the scaffolds and increased osteogenic capability under the application of a magnetic field, due to the activation of mechanotransduction processes.

conclusionThese results show that the developed 3D magnetic biofunctional scaffolds can be a very promising tool for advanced and personalised bone regeneration treatments.

Indexed as

Magnetic Iron Oxide NanoparticlesMagnetite NanoparticlesPrinting, Three-DimensionalTissue ScaffoldsHumansMesenchymal Stem CellsOsteogenesisPolyestersTissue EngineeringMagnetite NanoparticlesPolyestersBone tissue engineeringFused deposition modellingInkjet printingMechanotransductionSuperparamagnetic iron oxide nanoparticles

Identifiers

PMID40100619
PMCPMC12209090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.